Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.3 |
| Revenue growth | | | | | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.8 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.6 |
| Gross margin | | | | | | | | -31.2% |
| Selling, general and administrative | 36.2 | 25.8 | 29.9 | | | | | |
| Research and development | | | | 24.6 | 15.9 | 14.3 | 11.9 | |
| General and administrative | | | | 8.3 | 13.7 | 9.1 | 6.1 | 2.6 |
| EBIT | 0.0 | 0.0 | 0.0 | -32.9 | -29.7 | -23.4 | -17.9 | -10.8 |
| EBIT margin | | | | | | | | -131.2% |
| Pre-tax income | -36.8 | -28.0 | -32.2 | -33.0 | -29.4 | -23.8 | -24.4 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -36.8 | -28.0 | -32.2 | -33.0 | -29.4 | -23.8 | -24.4 | 0.0 |
| Net margin | | | | | | | | 0.0% |
| |
| Diluted EPS | ($1.30) | ($1.02) | ($1.31) | ($1.77) | ($1.59) | ($8.04) | ($25.01) | |
| Shares outstanding (diluted) | 28.4 | 27.4 | 24.6 | 18.6 | 18.6 | 3.0 | 1.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|